About BioIntelliSense
BioIntelliSense is a continuous health monitoring and clinical intelligence company that delivers scalable patient monitoring solutions for both in-facility and at-home care settings. The company's flagship BioButton wearable device continuously captures vital signs including heart rate, respiratory rate, skin temperature, and activity levels, transmitting data via Bluetooth to cloud-based analytics platforms. The system is designed to proactively identify early signs of patient deterioration through advanced vitals trending data, enabling clinicians to intervene earlier and improve patient outcomes. BioIntelliSense's monitoring solution integrates with electronic medical records (EMR) and supports various care delivery models including virtual nursing, telemetry overuse reduction programs, and remote patient monitoring (RPM) reimbursement initiatives. The technology has demonstrated clinical impact in reducing unplanned ICU admissions, rapid response team activations, and average length of hospital stay. With a discrete, comfortable design and 14-day battery life, the BioButton device serves health systems, hospitals, and post-acute care providers seeking to enhance patient safety while improving operational efficiency and nurse satisfaction. The company's Data-as-a-Service platform transforms raw vital sign data into actionable clinical insights displayed through the BioDashboard interface, helping care teams prioritize patients who need attention most.
Clinical Focus
Medical conditions and clinical areas addressed by BioIntelliSense.
Who It Serves
Milestones & Awards
Recent Milestones
Published observational study in Journal of Clinical Medicine with nearly 12,000 hospitalized patients (2024). Houston Methodist ICU transfer results study published (2025). Participation in Rural Health Transformation (RHT) Program.
Key Partnerships
Social & Media
Latest Updates
Solving for Telemetry Overuse in Patient Monitoring with BioIntelliSense
BioIntelliSense Partners with Hicuity Health
BioIntelliSense Announces FDA Clearance of the BioButton® Multi-Patient Wearable and BioDashboard™
Earlier Detection, Better Outcomes: Houston Methodist ICU Transfer Results with BioButton
Houston Methodist and BioIntelliSense Announce Strategic Collaboration
Company Details
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingOfficial Sources
Similar Companies in this Market
View all 63 →
Acurable
Acurable creates accurate and user-friendly wearable medical devices for at-home monitoring of sleep apnea, epilepsy, COPD, and asthma.
Aktiia
Aktiia develops optical blood pressure monitoring technology integrated into wearable devices for continuous, cuffless blood pressure tracking. The company focuses on enabling remote patient monitoring and hypertension management through clinically validated wearable solutions.
August Health
August Health provides an AI-enabled EHR platform designed specifically for senior living communities. The platform includes integrated modules for electronic health records, medication management (eMAR), move-ins, billing, care tracking, and predictive analytics to help operators shift from reactive to proactive care strategies.
Babyscripts
Babyscripts is a market-leading digital maternity care platform that combines remote patient monitoring, care management, and patient engagement tools to improve maternal health outcomes across prenatal and postpartum care for health systems, payers, and private practices.
Belun Technology Company
11-50 employees
Belun Technology develops FDA-cleared AI-powered wearable ring technology for sleep apnea diagnosis and continuous health monitoring. The company provides medical-grade sleep diagnostics that bridge the gap between home and hospital care.
Binah.ai
Binah.ai provides an AI-powered, video-based, 100% software solution that enables measurement of vital signs and health indicators using smartphone or tablet cameras. In 35 seconds, users can measure vital signs, chronic disease risks, stress levels, and bloodless blood tests without wearables or equipment.
Biobeat
Biobeat develops FDA-cleared cuffless ambulatory blood pressure monitoring (ABPM) solutions using a wireless, non-invasive chest patch. The company enables 24-hour hypertension monitoring for cardiologists, nephrologists, and hypertension centers to improve diagnosis accuracy and treatment management.
Biofourmis
growth · 350 employees
Biofourmis provides a connected technology platform that partners with health systems, hospitals, and payers to revolutionize care delivery across the continuum.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.